Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

dosimetry

  • The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
    Open Access
    The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
    Jan Taprogge, Carla Abreu, Siraj Yusuf, Gemma Ainsworth, Rachel H. Phillip, Jonathan I. Gear, Rebecca Gregory, Francesca Leek, Iain Murray, Amy B. Coulson, Sarah R. Brown, Yong Du, Kate Newbold, Jonathan Wadsley and Glenn D. Flux
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1125-1130; DOI: https://doi.org/10.2967/jnumed.122.264913
  • Efficacy and Safety of <sup>124</sup>I-MIBG Dosimetry-Guided High-Activity <sup>131</sup>I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
    You have access
    Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
    Ines Maric, Manuel Weber, Andre Prochnow, Jochen Schmitz, Nicole Unger, Benedikt M. Schaarschmidt, Thorsten D. Poeppel, Christoph Rischpler, Andreas Bockisch, Ken Herrmann, Walter Jentzen and Wolfgang P. Fendler
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.122.264775
  • <sup>64</sup>Cu Treatment Planning and <sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
    You have access
    64Cu Treatment Planning and 67Cu Therapy with Radiolabeled [64Cu/67Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
    Dale L. Bailey, Kathy P. Willowson, Matthew Harris, Colin Biggin, Alireza Aslani, Nigel A. Lengkeek, Jon Stoner, M. Enid Eslick, Harry Marquis, Michelle Parker, Paul J. Roach and Geoffrey P. Schembri
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 704-710; DOI: https://doi.org/10.2967/jnumed.122.264586
  • Biodistribution, Dosimetry, and Pharmacokinetics of <sup>68</sup>Ga-CBP8: A Type I Collagen–Targeted PET Probe
    You have access
    Biodistribution, Dosimetry, and Pharmacokinetics of 68Ga-CBP8: A Type I Collagen–Targeted PET Probe
    David Izquierdo-Garcia, Pauline Désogère, Mariane Le Fur, Sergey Shuvaev, Iris Y. Zhou, Ian Ramsay, Michael Lanuti, Onofrio A. Catalano, Ciprian Catana, Peter Caravan and Sydney B. Montesi
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 775-781; DOI: https://doi.org/10.2967/jnumed.122.264530
  • First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging
    Open Access
    First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging
    Richard Laforest, Anchal Ghai, Tyler J. Fraum, Reiko Oyama, Jennifer Frye, Helen Kaemmerer, Greg Gaehle, Tom Voller, Cedric Mpoy, Buck E. Rogers, Mark Fiala, Kooresh I. Shoghi, Samuel Achilefu, Michael Rettig, Ravi Vij, John F. DiPersio, Sally Schwarz, Monica Shokeen and Farrokh Dehdashti
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 320-328; DOI: https://doi.org/10.2967/jnumed.122.264349
  • A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After <sup>177</sup>Lu-Peptide Receptor Radionuclide Therapy
    You have access
    A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After 177Lu-Peptide Receptor Radionuclide Therapy
    Yuni K. Dewaraja, David M. Mirando, Avery B. Peterson, Jeremy Niedbala, John D. Millet, Justin K. Mikell, Kirk A. Frey, Ka Kit Wong, Scott J. Wilderman and Aaron S. Nelson
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1665-1672; DOI: https://doi.org/10.2967/jnumed.121.263738
  • You have access
    Dosimetry in Radiopharmaceutical Therapy
    Joe O’Donoghue, Pat Zanzonico, John Humm and Adam Kesner
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1467-1474; DOI: https://doi.org/10.2967/jnumed.121.262305
  • MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling
    Open Access
    MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling
    Sumudu Katugampola, Jianchao Wang, Alex Rosen and Roger W. Howell
    Journal of Nuclear Medicine September 1, 2022, 63 (9) 1441-1449; DOI: https://doi.org/10.2967/jnumed.121.263253
  • Prostate-Specific Membrane Antigen Radioligand Therapy Using <sup>177</sup>Lu-PSMA I&amp;T and <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry
    You have access
    Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry
    Christiane Schuchardt, Jingjing Zhang, Harshad R. Kulkarni, Xiaoyuan Chen, Dirk Müller and Richard P. Baum
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1199-1207; DOI: https://doi.org/10.2967/jnumed.121.262713
  • Biodistribution and Radiation Dosimetry of Intraperitoneally Administered <sup>124</sup>I-Omburtamab in Patients with Desmoplastic Small Round Cell Tumors
    You have access
    Biodistribution and Radiation Dosimetry of Intraperitoneally Administered 124I-Omburtamab in Patients with Desmoplastic Small Round Cell Tumors
    Milan Grkovski, Shakeel Modak, Pat B. Zanzonico, Jorge A. Carrasquillo, Steven M. Larson, John L. Humm and Neeta Pandit-Taskar
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 1094-1100; DOI: https://doi.org/10.2967/jnumed.121.262793

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 14
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire